As publicly traded companies that participate in the laboratory instrumentation space begin to release their annual reports, the SDi team of expert analysts is hard at work compiling data to prepare the highly anticipated 2022 edition of our flagship annual report, the SDi Global Assessment Report. As always, we strive to provide the gold standard […]
About Alice Kan
Alice is a senior market analyst who recently joined the SDi team as the resident life sciences guru. She studied at UCR, receiving an MS in molecular genetics and an MBA. Outside of the office, Alice enjoys collecting spooky things and living every day like it's Halloween.
Entries by Alice Kan
Cell and gene therapy (CGT) is a rapidly evolving field producing powerful new treatments for cancers and genetic diseases, with promising developments expanding into autoimmune disease, cardiovascular disease, musculoskeletal disease, and many others as well. The CGT field has generated great interest and hope among researchers, patient groups, and regulators, which has led to huge […]
This month marked the anniversary of the World Health Organization’s declaration of the SARS-CoV-2 outbreak as a pandemic. Virtually all aspects of normal life and business were quickly disrupted by the novel and deadly coronavirus as it spread across the world. But researchers and the analytical instrumentation companies that supply them rose to the occasion. […]
Over the course of the COVID-19 pandemic, the supply chain for meat has made the headlines numerous times, as COVID-19 outbreaks at meat processing plants have intermittently disrupted food supplies. While this has caused occasional inconvenience to consumers hoping to enjoy a delicious steak for diner, many other industries that rely on animal products are […]
Throughout the course of the COVID-19 pandemic thus far, much of our attention at SDi has been on technologies that have benefited in the wake of the pandemic. The few bright spots in an otherwise dismal market have been technologies used in clinical diagnostic testing for COVID-19, the illness caused by the SARS-CoV-2 virus. To […]
The world has changed in ways that would have been difficult to imaging just five months ago, when SDi released its flagship Global Assessment Report in February 2020. In that time, COVID-19 has dominated our lives, leaving no one untouched health wise, economically, or socially. For most involved in laboratory research and development, the first […]
The companies that manufacture the analytical instruments used in drug discovery and development are eyeing a market opportunity in the Contract Research Organization (CRO) industry. According to our latest report, the rush to develop new therapeutics in response to the COVID-19 pandemic has caused a flurry of activity in the pharma/bio sector, even as many […]
Politico reported today that CDC Director Robert Redfield said on Tuesday that he is not confident that U.S. labs have an adequate stock of the supplies used to extract genetic material from any virus in a patient’s sample — a critical step in coronavirus testing. The article goes on to quote Michael Mina, MD, PhD […]
June 14, 2021 1:52 pm
April 27, 2021 7:19 am
Strategic Directions International (SDi), part of Science and Medicine Group, is the leading business intelligence firm in the highly specialized field of analytical and life science instruments. Its client list includes virtually every major analytical instrumentation company in the United States, Europe, and Japan. Founded in 1981, the Los Angeles-based company has published hundreds of market reports and provided proprietary consulting services for a multitude of clients.